241 related articles for article (PubMed ID: 30621793)
1. Risk of bias assessment of sequence generation: a study of 100 systematic reviews of trials.
Wuytack F; Regan M; Biesty L; Meskell P; Lutomski JE; O'Donnell M; Treweek S; Devane D
Syst Rev; 2019 Jan; 8(1):13. PubMed ID: 30621793
[TBL] [Abstract][Full Text] [Related]
2. Risk of bias judgments for random sequence generation in Cochrane systematic reviews were frequently not in line with Cochrane Handbook.
Barcot O; Boric M; Poklepovic Pericic T; Cavar M; Dosenovic S; Vuka I; Puljak L
BMC Med Res Methodol; 2019 Aug; 19(1):170. PubMed ID: 31382898
[TBL] [Abstract][Full Text] [Related]
3. The judgement of biases included in the category "other bias" in Cochrane systematic reviews of interventions: a systematic survey.
Babic A; Pijuk A; Brázdilová L; Georgieva Y; Raposo Pereira MA; Poklepovic Pericic T; Puljak L
BMC Med Res Methodol; 2019 Apr; 19(1):77. PubMed ID: 30971219
[TBL] [Abstract][Full Text] [Related]
4. Risk of bias tools in systematic reviews of health interventions: an analysis of PROSPERO-registered protocols.
Farrah K; Young K; Tunis MC; Zhao L
Syst Rev; 2019 Nov; 8(1):280. PubMed ID: 31730014
[TBL] [Abstract][Full Text] [Related]
5. Are Neonatal Trials Better Conducted and Reported over the Last 6 Decades? An Analysis on Their Risk-of-Bias Status in Cochrane Reviews.
Lai NM; Ong JMJ; Chen KH; Chaiyakunapruk N; Ovelman C; Soll R
Neonatology; 2019; 116(2):123-131. PubMed ID: 31108494
[TBL] [Abstract][Full Text] [Related]
6. The effect of the CONSORT statement on the amount of "unclear" Risk of Bias reporting in Cochrane Systematic Reviews.
Rademaker MM; Ramakers GGJ; Smit AL; Hooft L; Stegeman I
PLoS One; 2020; 15(7):e0235535. PubMed ID: 32650340
[TBL] [Abstract][Full Text] [Related]
7. Cochrane risk of bias tool was used inadequately in the majority of non-Cochrane systematic reviews.
Puljak L; Ramic I; Arriola Naharro C; Brezova J; Lin YC; Surdila AA; Tomajkova E; Farias Medeiros I; Nikolovska M; Poklepovic Pericic T; Barcot O; Suarez Salvado M
J Clin Epidemiol; 2020 Jul; 123():114-119. PubMed ID: 32247026
[TBL] [Abstract][Full Text] [Related]
8. Disagreements in risk of bias assessment for randomized controlled trials in hypertension-related Cochrane reviews.
Yao Y; Shen J; Luo J; Li N; Liao X; Zhang Y
Trials; 2024 Jun; 25(1):405. PubMed ID: 38907276
[TBL] [Abstract][Full Text] [Related]
9. Risk of bias assessments for selective reporting were inadequate in the majority of Cochrane reviews.
Saric F; Barcot O; Puljak L
J Clin Epidemiol; 2019 Aug; 112():53-58. PubMed ID: 31009658
[TBL] [Abstract][Full Text] [Related]
10. Risk of bias over time in updates of Cochrane oral health reviews.
Faggion CM; Aranda L; Pandis N; Alarcón MA; Diaz KT
J Dent; 2019 Jan; 80():63-68. PubMed ID: 30342067
[TBL] [Abstract][Full Text] [Related]
11. Adequacy of risk of bias assessment in surgical vs non-surgical trials in Cochrane reviews: a methodological study.
Barcot O; Boric M; Dosenovic S; Cavar M; Jelicic Kadic A; Poklepovic Pericic T; Vukicevic I; Vuka I; Puljak L
BMC Med Res Methodol; 2020 Sep; 20(1):240. PubMed ID: 32993499
[TBL] [Abstract][Full Text] [Related]
12. High and unclear risk of bias assessments are predominant in diagnostic accuracy studies included in Cochrane reviews.
Di Girolamo N; Winter A; Meursinge Reynders R
J Clin Epidemiol; 2018 Sep; 101():73-78. PubMed ID: 29777798
[TBL] [Abstract][Full Text] [Related]
13. Risk of Bias in Iranian Randomized Trials Included in Cochrane Reviews.
Kabir A; Sofi-Mahmudi A; Karimi Behnagh A; Eidkhani V; Baradaran HR; Kabiri P; Haghdoost A; Mesgarpour B
Arch Iran Med; 2022 Jun; 25(6):375-382. PubMed ID: 35943017
[TBL] [Abstract][Full Text] [Related]
14. Risk of bias assessments and reporting quality of systematic reviews and randomized controlled trials examining acupuncture for depression: An overview and meta-epidemiology study.
Luo S; Long Y; Xiao W; Wang X; Chen R; Guo Q; Liu J; Shao R; Du L; Chen M
J Evid Based Med; 2020 Feb; 13(1):25-33. PubMed ID: 32112515
[TBL] [Abstract][Full Text] [Related]
15. Risk of Bias in Systematic Reviews of Non-Randomized Studies of Adverse Cardiovascular Effects of Thiazolidinediones and Cyclooxygenase-2 Inhibitors: Application of a New Cochrane Risk of Bias Tool.
Bilandzic A; Fitzpatrick T; Rosella L; Henry D
PLoS Med; 2016 Apr; 13(4):e1001987. PubMed ID: 27046153
[TBL] [Abstract][Full Text] [Related]
16. Disagreements in risk of bias assessment for randomised controlled trials included in more than one Cochrane systematic reviews: a research on research study using cross-sectional design.
Bertizzolo L; Bossuyt P; Atal I; Ravaud P; Dechartres A
BMJ Open; 2019 Apr; 9(4):e028382. PubMed ID: 30940766
[TBL] [Abstract][Full Text] [Related]
17. Poor reliability between Cochrane reviewers and blinded external reviewers when applying the Cochrane risk of bias tool in physical therapy trials.
Armijo-Olivo S; Ospina M; da Costa BR; Egger M; Saltaji H; Fuentes J; Ha C; Cummings GG
PLoS One; 2014; 9(5):e96920. PubMed ID: 24824199
[TBL] [Abstract][Full Text] [Related]
18. There were large discrepancies in risk of bias tool judgments when a randomized controlled trial appeared in more than one systematic review.
Jordan VM; Lensen SF; Farquhar CM
J Clin Epidemiol; 2017 Jan; 81():72-76. PubMed ID: 27622779
[TBL] [Abstract][Full Text] [Related]
19. Risk of bias of randomized trials over time.
Reveiz L; Chapman E; Asial S; Munoz S; Bonfill X; Alonso-Coello P
J Clin Epidemiol; 2015 Sep; 68(9):1036-45. PubMed ID: 26227423
[TBL] [Abstract][Full Text] [Related]
20. A protocol for a systematic review of non-randomised evaluations of strategies to improve participant recruitment to randomised controlled trials.
Gardner HR; Fraser C; MacLennan G; Treweek S
Syst Rev; 2016 Aug; 5(1):131. PubMed ID: 27485111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
